Profitability
Weight: 20%
B-
65
- 5yr Avg ROIC 8.0%
- Operating Margin Trend +4.95 pp/yr
RPRX
Royalty Pharma plc
AlphaQuality composite grade, weighted for stable earnings power businesses.
Capital Efficiency
Weight: 15%
D+
41
- 5yr Avg ROE 10.6%
- 5yr Share-Count CAGR 7.6%
Growth Quality
Weight: 15%
C
52
- 5yr Revenue CAGR 2.3%
- 5yr EPS CAGR 7.1%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 15%
A-
84
- 5yr FCF Margin 107.6%
- 5yr FCF/NI Conversion 12.48x
Balance Sheet
Weight: 20%
D
38
- Net Debt / EBITDA 5.08x
- Interest Coverage (EBIT/Int) 5.30x
- Altman Z-Score 2.21
Stability
Weight: 15%
D-
32
- EPS Volatility (σ/μ) 0.80
- Negative-Revenue Years (5) 2/5
- Piotroski F-Score 4
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 1 new buy; 2 trimmed.
- Holders
- 3 +1
- Avg Δ position
- -65.7%
- New buys
- 1
- Full exits
- 0